Skip to content

Clinical trials

Phase 3 Schizophrenia trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: India Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20063
20074
20086
20091
20105
20115
20171
20211
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Sumitomo Pharma America, Inc.5
AstraZeneca3
Forest Laboratories3
Janssen Research & Development, LLC3
Hoffmann-La Roche2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Vanda Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia33
Mental Disorders3
Psychotic Disorders3
Autistic Disorder1
Bipolar Disorder1
Mania1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.